Quick search:
Content Ideas
| Result | Content Idea | Research |
|---|---|---|
| Result | Content Idea | Research |
| 1 | Merck (MRK) to Help J&J Make COVID-19 Vaccine to Boost Supply |
|
| 2 | Why Merck (MRK) is a Top Dividend Stock for Your Portfolio |
|
| 3 | Merck & Co., Inc. (MRK) Presents at Cowen 41st Annual Health Care Conference (Transcript) |
|
| 4 | Merck to acquire Pandion for $2 billion (NYSE:MRK) |
|
| 5 | Merck & Co. (MRK) Q4 2020 Earnings Call Transcript |
|
| 6 | Merck: Positioned To Deliver For Dividend Investors In 2021 |
|
| 7 | Pharma Stock Roundup: SNY/GSK & PFE COVID-19 Vaccine Update, MRK's Pandion Buyout |
|
| 8 | Pharma Stock Roundup: PFE, MRK Q4 Earnings, AZN, JNJ Coronavirus Vaccine Updates |
|
| 9 | Analysts Think The Market Is All Wrong On Merck |
|
| 10 | Merck & Co., Inc. (MRK) Stock: Buy, Hold, or Sell? |
|
| 11 | How Much Are Merck & Co., Inc. (NYSE:MRK) Insiders Taking Off The Table? |
|
| 12 | Merck & Company Inc. (new) (MRK) Closes 0.65% Up on the Day for March 02 |
|
| 13 | FDA Requires Additional Data On Merck COVID-19 Drug, EUA Moved Back |
|
| 14 | Merck & Co Inc (MRK) 2 Day Down Streak Snapped, in a Downtrend Over Past 30 Days; Pin Bar Pattern Appearing on Chart |
|
| 15 | Merck’s Keytruda decision deferred |
|
| 16 | Notable Wednesday Option Activity: VLO, MRK, PAYC |
|
| 17 | Shareholders Of Merck (NYSE:MRK) Must Be Happy With Their 75% Return |
|
| 18 | NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch |
|
| 19 | Should Weakness in MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? |
|
| 20 | April 9th Options Now Available For Merck (MRK) |
|
| 21 | Merck (MRK) Confirms It Will Help Produce Johnson & Johnson's (JNJ) COVID-19 Vaccine; |
|
| 22 | Merck EPS misses by $0.07, misses on revenue |
|
| 23 | Merck & Co., Inc. (MRK) Stock: How Does it Score on Fundamental Metrics? |
|
| 24 | When to Buy Merck as Shares Fall After Earnings |
|
| 25 | Merck (MRK) To Buy Pandion Therapeutics (PAND) In $1.85 Billion Deal |
|
| 26 | Merck Q4 2020 Earnings Preview |
|
| 27 | Merck & Co., Inc. (NYSE:MRK) Expected to Announce Quarterly Sales of $12.85 Billion |
|
| 28 | Merck & Co Inc (MRK) Underperforms All mega cap US stocks, Down 0.33%; in a Downtrend Over Past 30 Days |
|
| 29 | Galaxy Mrk 335 examined with AstroSat |
|
| 30 | U.S. FDA Accepts Merck’s Gefapixant New Drug Application for Review |
|
| 31 | Dow Movers: MRK, AXP |
|
| 32 | Merck (MRK) Provides Update on KEYTRUDA Indication in Metastatic Small Cell Lung Cancer in the US |
|
| 33 | MRK: Is Merck a Good Value Stock to Buy? |
|
| 34 | Merck (MRK) Q4 Earnings & Sales Miss, CEO Frazier Steps Down |
|
| 35 | Research investigates variability of the blazar Mrk 421 |
|
| 36 | Here’s Why Merck Is A Better Pick Over Johnson & Johnson Stock |
|
| 37 | Merck Inks Deal To Buy Pandion Therapeutics For $1.85B; Shares Skyrocket |
|
| 38 | Merck & Company Inc. (new) (MRK) Closes 2.68% Down on the Day for February 26 |
|
| 39 | Pre-Market Earnings Report for February 4, 2021 : MRK, BMY, PM, CI, BDX, APD, BAX, BCE, CMI, PH, ALXN, YUM |
|
| 40 | Merck & Company Inc. (new) (MRK) Closes 0.17% Down on the Day for February 18 |
|
| 41 | Merck Q4 Keytruda sales up 28%, 2021 guidance tops consensus |
|
| 42 | Why Moderna Stock Is Sinking Again Today |
|
| 43 | Merck & Co Inc (MRK) Makes Big Move Relative to Two Week Trend, Down 2.68%; in a Downtrend Over Past 30 Days |
|
| 44 | Health Care Sector Update for 02/17/2021: NKTR,MRK,VRCA,KOD |
|
| 45 | NKTR Stock Breaks Out; Plans Combo Study With Merck's Keytruda |
|
| 46 | Merck/Eisai's Keytruda-Lenvima Combo Tops Standard Of Care In Late-Stage Kidney Cancer Study |
|
| 47 | 'Biden to announce 'historic partnership': Merck will help make Johnson & Johnson coronavirus vaccine, officials say' -Washington Post |
|
| 48 | Merck antiviral molnupiravir effective for COVID-19 |
|
| 49 | Merck & Co., Inc. (NYSE:MRK) Stock Rating Reaffirmed by Cantor Fitzgerald |
|
| 50 | Merck & Co Inc. (NYSE:MRK) Enters License and Collaboration Agreement With Artiva Biotherapeutics for CAR-NK Therapies |
|
| 51 | Health Care Sector Update for 02/04/2021: MRK |
|
| 52 | $1.68 EPS Expected for Merck & Co., Inc. (NYSE:MRK) This Quarter |
|
| 53 | Merck Posts Mixed Q4 Earnings; Kenneth Frazier To Step Down As CEO |
|
| 54 | Merck Q4 Earnings Preview: Keytruda And Gardasil In Focus |
|
| 55 | Merck Begins Tender Offer to Acquire Pandion Therapeutics |
|
| 56 | Did Merck Make a Mistake With a Key FDA Filing? |
|
| 57 | Merck & Company Inc. (new) (MRK) Closes 0.2% Down on the Day for February 11 |
|
| 58 | Biden to announce that pharmaceutical giant Merck (MRK) will help make Johnson & Johnson (JNJ) coronavirus vaccine in pact between competitors |
|
| 59 | Wall Street Starts a Fresh Week at Record Highs |
|
| 60 | Merck to Present New Data from Various HIV Research and Development Programs at CROI 2021 |
|
| 61 | Merck & Co., Inc. Just Missed Earnings |
|
| 62 | The Vanguard Health Care Fund Exits Medtronic, Merck & Co |
|
| 63 | Global Disposable Gloves Market 2021 – Glove Corp., Shield Scientific, Rubberex, MRK Healthcare, Supermax Corp |
|
| 64 | Merck & Co., Inc. Forecasted to Earn Q2 2021 Earnings of $1.64 Per Share (NYSE:MRK) |
|
| 65 | Warren Buffett’s Berkshire Hathaway Bought Verizon and Chevron. Here’s What Else It Traded. |
|
| 66 | Merck: 4Q Earnings Snapshot |
|
| 67 | Merck & Co., Inc. to Host Earnings Call |
|
| 68 | Merck Announces Fourth-Quarter and Full-Year 2020 Financial Results |
|
| 69 | 2 Top Stocks to Buy for a Post-Pandemic World |
|
| 70 | The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data |
|
| 71 | Merck's Cough Drug Gefapixant Application Accepted For US Review |
|
| 72 | Merck & Co., Inc. (MRK) Set to Announce Quarterly Earnings on Thursday |
|
| 73 | Merck to Present at the Cowen 41st Annual Health Care Conference |
|
| 74 | Merck Taps Davis as Next CEO as Frazier Sets Plan to Retire |
|
| 75 | Treasuries Give Back Ground Amid Optimism About Vaccines |
|
| 76 | Merck Announces Fifth Round of Global Grants to Tackle Maternal Mortality and Promote Health Equity Worldwide |
|
| 77 | Stocks Extend Losses Despite Easing Inflation Fears |
|
| 78 | Merck Stock |
|
| 79 | Recap: Merck & Co Q4 Earnings |
|
| 80 | Nasdaq Plunges To Nearly Two-Month Closing Low As Bond Yields Rebound |
|
| 81 | Merck (MRK) Stock Sinks As Market Gains: What You Should Know |
|
| 82 | Merck to Present at the Barclays Global Healthcare... | INN |
|
| 83 | Nektar Posts Better-Than-Feared Quarterly Loss, Misses On Revenues |
|
| 84 | Consider Buying This Blue Chip on the Dip |
|
| 85 | Latest Update on Collaborative Robot (Cobot) Market 2021: Scenario, Key Driven Factors, New Investment And Industry Outlook | Top Booming Companies – Kawasaki Heavy Industries, Precise Automation, MRK-Systeme – KSU | The Sentinel Newspaper |
|
| 86 | SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Pandion Therapeutics, Inc. Buyout |
|
| 87 | Jim Cramer: The Rush to Reopen Is Ill-Advised |
|
| 88 | PANDION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PAND and Encourages Investors to Contact the Firm |
|
| 89 | Pharma ETFs in Focus Post Q4 Earnings |
|
| 90 | Merck (MRK) Outpaces Stock Market Gains: What You Should Know |
|
| 91 | Is Merck (MRK) A Good Stock To Buy Now? |
|
| 92 | Prem Watsa's Top 5 Trades of the 4th Quarter |
|
| 93 | 3 Under-the-Radar Biotech Stocks to Buy After Dull Earnings Reactions |
|
| 94 | Merck and Teva in talks to join COVID-19 vaccine production |
|
| 95 | Merck (MRK) Dips More Than Broader Markets: What You Should Know |
|
| 96 | Seagen (SGEN) Q4 Earnings Beat Estimates, Revenues Rise Y/Y |
|
| 97 | Hillman Capital's Top 4 Buys of the 4th Quarter |
|
| 98 | What Will the Stock Market Do Today? 3 Big Stories to Watch. |
|
| 99 | Merck (MRK) Gains As Market Dips: What You Should Know |
|
| 100 | Just Four Days Till Merck & Co., Inc. (NYSE:MRK) Will Be Trading Ex-Dividend |
|